Delisting Determination, The Nasdaq Stock Market, LLC,
December 29, 2022,  ZyVersa Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined
to remove from listing the warrants of ZyVersa Therapeutics,
Inc. (the Company), effective at the opening of the trading
session on January 9, 2023.
Based on review of information provided by the Company,
Exchange Staff determined that the Company warrants no longer
qualified for listing on the Exchange pursuant to Listing Rule
IM-5101-2.
The Company was notified of the Staff determination on December
12, 2022. The Company did not appeal the Staff determination to
the Hearings Panel. The Staff determination to delist the
Company warrants became final on December 21, 2022.